Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cue Biopharma (CUE) Other Non Operating Income (2018 - 2020)

Historic Other Non Operating Income for Cue Biopharma (CUE) over the last 3 years, with Q3 2020 value amounting to -$23000.0.

  • Cue Biopharma's Other Non Operating Income fell 56000.0% to -$23000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was -$86922.0, marking a year-over-year decrease of 16064.17%. This contributed to the annual value of $64078.0 for FY2019, which is 6124.4% down from last year.
  • Cue Biopharma's Other Non Operating Income amounted to -$23000.0 in Q3 2020, which was down 56000.0% from -$25000.0 recorded in Q2 2020.
  • Cue Biopharma's 5-year Other Non Operating Income high stood at $98000.0 for Q3 2018, and its period low was -$26000.0 during Q1 2020.
  • Its 3-year average for Other Non Operating Income is $14128.6, with a median of $2000.0 in 2018.
  • As far as peak fluctuations go, Cue Biopharma's Other Non Operating Income surged by 470000.0% in 2019, and later plummeted by 56000.0% in 2020.
  • Over the past 3 years, Cue Biopharma's Other Non Operating Income (Quarter) stood at $66337.0 in 2018, then plummeted by 119.48% to -$12922.0 in 2019, then tumbled by 77.99% to -$23000.0 in 2020.
  • Its Other Non Operating Income stands at -$23000.0 for Q3 2020, versus -$25000.0 for Q2 2020 and -$26000.0 for Q1 2020.